Khon Kaen news coverage via Yahoo! Singapore
recent updated : March 17, 2015, 3:19 am
Rich Pharmaceuticals, Inc. Names Chittima Sirijerachai, MD as Principal Investigator for Upcoming AML Clinical Trials
BEVERLY HILLS, Calif., March 12, 2015 :PRNewswire: --Rich Pharmaceuticals, Inc.(RCHA) (-quot:Rich Pharmaceuticals-quot: or the -quot:Company-quot:), a clinical-stage biotechnology company focused on developing innovative therapies in oncology, with initial concentration in treating Acute Myelocytic Leukemia (AML) and Hodgkin-:39:s Lymphoma, announced that Dr. Chittima Sirijerachai has committed to becoming a ...
Cannes: Todd McCarthy on the Possibilities, Probabilities and Near-Shoo-Ins
THR-:39:s chief film critic takes a look at the movies with the best shot of scoring a coveted slot at the 68th edition of the world-:39:s most prestigious cinema event.